ロード中...
SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes
Immunosuppressive therapy (IST) yields durable hematologic improvement in a subset of patients with lower-risk myelodysplastic syndrome (MDS). We investigated the effect of somatic gene mutations on response to IST in lower-risk MDS. Among 40 patients evaluated by next-generation sequencing, the pre...
保存先:
| 出版年: | Clin Lymphoma Myeloma Leuk |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7771378/ https://ncbi.nlm.nih.gov/pubmed/32179032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2019.12.023 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|